Q1 FY2027 results announced. Revenue is expected to increase versus the previous quarter, with operating income and net income surpassing the year-ago level. Segments indicate solid growth in Vision Care, supported by strengthened domestic and international channels and new product launches, positive for the outlook.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"7780","jir_company_name":"Menicon Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-08-07","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/08\/7780-20260807-01.pdf","jir_short_summary":"Q1 FY2027 results announced. Revenue is expected to increase versus the previous quarter, with operating income and net income surpassing the year-ago level. Segments indicate solid growth in Vision Care, supported by strengthened domestic and international channels and new product launches, positive for the outlook.","jir_summary":"### Section Heading\nUnder Vision2030, the 1DAY Global strategy is pursued, continuing growth in core businesses and expansion into new areas. Segment-wise, higher Vision Care-related revenue is anticipated, supported by strengthened domestic and international sales channels and new product launches. Financially, revenue growth is accompanied by operating and net income ahead of the prior-year period.\n\n### Section 2 Heading\nIn detail of the financial position, disclosure covers the composition of assets and liabilities, cash flows, and major items in the quarterly consolidated income statement. Notably, segment profitability contributions and cost structure revisions are implied, providing material insight into earnings stability. Looking ahead, global market expansion and new product introductions are expected to support higher profitability.","jir_financial_highlights":"Net sales: 30,251 (YoY+?)\nOperating income: 3,429 (YoY+?)\nOrdinary income: 3,361 (YoY+90.1%)\nNet income attributable to owners of the parent: 2,230 (YoY+124.9%)","jir_category":"","jir_hashtags":"#MeniconBusinessStrategy, #EarningsFlash, #MedicalDevicesContactLenses","jir_key_figures":"Net sales: 30,251 (million yen)\nOperating income: 3,429 (million yen)\nOrdinary income: 3,361 (million yen)","jir_meta_title":"\u3010Menicon\u3011FY2027 Q1 Earnings Summary\uff5cNet sales 30,251 million yen, Ordinary income 3,361 million yen","jir_meta_description":"Summary of Menicon's FY2027 Q1 earnings summary. Net sales are expected to increase YoY; operating income and net income are ahead of the previous year. Explains segment growth drivers and outlook.","jir_og_title":"\u3010Menicon\u3011Earnings Release: Q1 Net sales 30,251 million yen, Ordinary income 3,361 million yen","jir_og_description":"Menicon's Q1 earnings. Revenue is steady, ordinary income and net income rise YoY. Details on future growth strategy and segment trends.","jir_og_image_url":"\/assets\/og\/company-financial_summary.jpg","jir_chart_data_collection":"[{\"jir_chart_id\": \"revenue_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Revenue Trend\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"2026Q1\\\",\\\"2026Q2\\\",\\\"2026Q3\\\",\\\"2026Q4\\\",\\\"2027Q1\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Net sales\\\",\\\"data\\\":[30251,?, ?, ?, 30251}]}]}}\"}, {\"jir_chart_id\": \"operating_profit_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Operating Income Trend\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"2026Q1\\\",\\\"2026Q2\\\",\\\"2026Q3\\\",\\\"2026Q4\\\",\\\"2027Q1\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Operating income\\\",\\\"data\\\":[3429, ?, ?, ?, 3429}]}]}}\"}, {\"jir_chart_id\": \"segment_revenue_breakdown\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Segment Revenue\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Vision Care\\\",\\\"Other\\\"],\\\"datasets\\\":[{\\\"data\\\":[?,?],\\\"backgroundColor\\\":[\\\"#4e79a7\\\",\\\"#f28e2b\\\"]}]} }\"}, {\"jir_chart_id\": \"margin_analysis\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Profit Margin Analysis\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Net sales\\\",\\\"Operating income\\\",\\\"Ordinary income\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Margin\\\",\\\"data\\\":[?, ?, ?]}]}}\"}, {\"jir_chart_id\": \"guidance_comparison\", \"jir_chart_type\": \"table\", \"jir_chart_title\": \"Forecast vs Actual\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"table\\\",\\\"columns\\\":[\\\"Item\\\",\\\"Actual\\\",\\\"Forecast\\\"],\\\"rows\\\":[[\\\"Net sales\\\",\\\"30251\\\",\\\"\\\"],[\\\"Operating income\\\",\\\"3429\\\",\\\"\\\"],[\\\"Net income\\\",\\\"2230\\\",\\\"\\\"]]}\"}]","ir_related_company":9426,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-99202","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n